CRIS Current Research Information System

PANTALEO, MARIA ABBONDANZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.238
AS - Asia 14.769
EU - Europa 10.260
AF - Africa 986
Continente sconosciuto - Info sul continente non disponibili 882
SA - Sud America 856
OC - Oceania 26
Totale 45.017
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.912
SG - Singapore 3.967
VN - Vietnam 3.901
CN - Cina 3.704
IT - Italia 2.237
GB - Regno Unito 2.050
DE - Germania 1.158
SE - Svezia 1.102
HK - Hong Kong 960
FR - Francia 681
IN - India 643
RU - Federazione Russa 576
BR - Brasile 554
IE - Irlanda 411
CH - Svizzera 385
BD - Bangladesh 345
FI - Finlandia 323
KR - Corea 317
NL - Olanda 311
UA - Ucraina 301
CI - Costa d'Avorio 265
ZA - Sudafrica 249
JP - Giappone 238
TG - Togo 215
CA - Canada 189
EE - Estonia 164
AR - Argentina 110
SC - Seychelles 105
AT - Austria 104
PL - Polonia 89
ID - Indonesia 88
JO - Giordania 88
PH - Filippine 87
BG - Bulgaria 86
BE - Belgio 74
NG - Nigeria 68
TH - Thailandia 63
IQ - Iraq 58
TW - Taiwan 54
MX - Messico 53
TR - Turchia 43
EC - Ecuador 42
ES - Italia 40
CO - Colombia 38
PK - Pakistan 38
CL - Cile 36
GR - Grecia 36
IR - Iran 30
AU - Australia 23
MY - Malesia 23
SA - Arabia Saudita 21
PY - Paraguay 20
UZ - Uzbekistan 20
JM - Giamaica 19
LT - Lituania 19
RO - Romania 18
CR - Costa Rica 17
PE - Perù 17
VE - Venezuela 17
HR - Croazia 16
UY - Uruguay 16
MA - Marocco 14
LB - Libano 13
EG - Egitto 11
SK - Slovacchia (Repubblica Slovacca) 11
CZ - Repubblica Ceca 10
ET - Etiopia 9
KE - Kenya 9
NI - Nicaragua 9
PT - Portogallo 9
TN - Tunisia 9
AO - Angola 8
DZ - Algeria 8
IL - Israele 8
AE - Emirati Arabi Uniti 7
NO - Norvegia 7
NP - Nepal 7
AL - Albania 6
HU - Ungheria 6
RS - Serbia 6
DK - Danimarca 5
GT - Guatemala 5
LA - Repubblica Popolare Democratica del Laos 5
MU - Mauritius 5
PR - Porto Rico 5
PS - Palestinian Territory 5
SI - Slovenia 5
BA - Bosnia-Erzegovina 4
HN - Honduras 4
MM - Myanmar 4
OM - Oman 4
PA - Panama 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GH - Ghana 3
Totale 44.081
Salva come PNG Salva come JPEG
Città #
Singapore 2.770
Ashburn 1.900
Southend 1.784
Fairfield 1.462
Chandler 1.165
San Jose 934
Hong Kong 891
Ho Chi Minh City 829
Woodbridge 736
Hanoi 681
Wilmington 676
Houston 674
Hefei 661
Santa Clara 631
Seattle 627
Bologna 555
Cambridge 498
Princeton 488
Beijing 469
Dong Ket 458
Ann Arbor 444
Council Bluffs 423
Dublin 412
Boardman 409
Bern 345
Seoul 275
New York 273
Lauterbourg 268
Abidjan 265
Los Angeles 260
Helsinki 257
Dallas 233
Lomé 215
Nanjing 208
Westminster 195
Tokyo 190
Redmond 184
Padova 159
Berlin 157
Jacksonville 156
Haiphong 140
Milan 139
Buffalo 124
Da Nang 122
Jinan 116
São Paulo 110
Frankfurt am Main 105
Turin 96
Redondo Beach 95
Rome 94
San Diego 91
Amman 86
Shenyang 86
Sofia 86
Chicago 77
Guangzhou 77
Munich 75
Saint Petersburg 75
Changsha 73
Toronto 73
Warsaw 72
Brussels 67
Nanchang 67
Phoenix 66
Bengaluru 63
Vienna 62
Abeokuta 61
Shanghai 61
Hebei 60
Medford 59
Jakarta 58
Tianjin 57
Falls Church 56
Johannesburg 56
Des Moines 54
Zhengzhou 51
Hangzhou 50
Jiaxing 50
Montreal 50
Florence 49
London 49
Bremen 48
Orem 48
Biên Hòa 47
Lappeenranta 45
Dearborn 42
Hyderabad 42
Amsterdam 40
Hải Dương 40
Atlanta 39
Mülheim 39
Yubileyny 39
San Francisco 38
Denver 36
Olalla 36
Nuremberg 35
Shenzhen 35
The Dalles 35
Brooklyn 34
Kuban 33
Totale 28.126
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 470
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 403
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 305
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 284
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 278
Hippo pathway targeting in TP53-mutant Uterine Leiomyosarcoma 275
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options 266
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 265
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 264
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 261
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 259
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 253
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 251
Cardiac metastasis of melanoma. 250
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 249
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses 249
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 248
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 247
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 240
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 239
Genomic Characterization of Rare Primary Cardiac Sarcoma Entities 235
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 231
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 231
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 229
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 228
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 227
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 226
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 225
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 223
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies 220
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 217
The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility 217
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors 216
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 215
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 214
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs 213
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 213
Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches 213
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 213
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 212
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 212
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 212
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 212
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 211
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 211
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 210
Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading 209
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. 208
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 208
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 207
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 204
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 203
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 203
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. 203
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 201
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 201
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment 201
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 200
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 199
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 198
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 198
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 197
Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas 196
In Reply 196
The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST) 196
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 194
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 194
Efficacy and biological activity of imatinib in metastatic Dermatofibrosarcoma Protuberans (DFSP) 193
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 192
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 192
Activity of sunitinib in extraskeletal myxoid chondrosarcoma. 192
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 191
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 191
Mechanisms of resistance to a PI3K inhibitor in gastrointestinal stromal tumors: an omic approach to identify novel druggable targets 191
Multimodality Imaging in the Diagnostic Work-Up of Patients With Cardiac Masses 190
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 190
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib. 189
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 188
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 188
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 186
ACTIVATED NF-KB IN COLORECTAL CANCER: PREDICTIVE OR PROGNOSTIC FACTOR? 186
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 186
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 185
Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review. 183
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 182
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 182
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy 180
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 180
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 180
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 180
SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update 179
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean 177
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 177
Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis 177
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence A Report From the Italian Sarcoma Group 176
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 176
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ 176
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 175
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 174
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study 174
Totale 21.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.150 0 183 229 367 388 211 108 395 256 277 968 768
2022/20235.399 587 782 291 634 325 352 153 323 859 172 398 523
2023/20241.665 169 262 89 185 132 301 85 122 60 84 86 90
2024/20256.067 294 802 534 440 933 287 478 257 114 427 311 1.190
2025/202615.656 1.485 1.279 1.297 1.092 1.544 879 1.817 483 3.180 1.260 713 627
2026/20271.017 444 573 0 0 0 0 0 0 0 0 0 0
Totale 45.017